Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?
暂无分享,去创建一个
P. Friedmann | E. Nunes | R. Bonnie | C. O'brien | Sean M. Murphy | Joshua D. Lee | M. Gordon | Donna T Chen | Donna Wilson | T. Boney | Randall Hoskinson